玻璃酸钠注射结合乙哌立松口服治疗膝骨关节炎的疗效分析

钱臣, 卞晓星

钱臣, 卞晓星. 玻璃酸钠注射结合乙哌立松口服治疗膝骨关节炎的疗效分析[J]. 实用临床医药杂志, 2014, (7): 44-47,61. DOI: 10.7619/jcmp.201407013
引用本文: 钱臣, 卞晓星. 玻璃酸钠注射结合乙哌立松口服治疗膝骨关节炎的疗效分析[J]. 实用临床医药杂志, 2014, (7): 44-47,61. DOI: 10.7619/jcmp.201407013
QIAN Chen, BIAN Xiaoxing. Efficacy of hyaluronan combined with eperisone hydrochloride in treatment of patients with knee osteoarthritis[J]. Journal of Clinical Medicine in Practice, 2014, (7): 44-47,61. DOI: 10.7619/jcmp.201407013
Citation: QIAN Chen, BIAN Xiaoxing. Efficacy of hyaluronan combined with eperisone hydrochloride in treatment of patients with knee osteoarthritis[J]. Journal of Clinical Medicine in Practice, 2014, (7): 44-47,61. DOI: 10.7619/jcmp.201407013

玻璃酸钠注射结合乙哌立松口服治疗膝骨关节炎的疗效分析

详细信息
  • 中图分类号: R684.3

Efficacy of hyaluronan combined with eperisone hydrochloride in treatment of patients with knee osteoarthritis

  • 摘要: 目的:对比研究玻璃酸钠联合乙哌立松与单用玻璃酸钠或者单用乙哌立松治疗早中期膝关节骨关节炎的临床疗效。方法门诊选取膝关节骨关节炎患者99例,随机分组,单盲给药,玻璃酸钠治疗组、乙哌立松治疗组和玻璃酸钠结合乙哌立松治疗组各33例,玻璃酸钠结合乙哌立松治疗组予玻璃酸钠关节腔注射及乙哌立松口服治疗,另两组分别单独予玻璃酸钠关节腔注射和乙哌立松口服治疗。比较3组用药后临床症状改善情况及软骨磨损严重程度并作统计学分析。结果经5周治疗后,WOMAC 评分玻璃酸钠结合乙哌立松治疗组均显著低于两单独用药组;尿中 CTX-Ⅱ水平玻璃酸钠结合乙哌立松治疗组明显低于两单独用药组,差异有显著性(P <0.05)。结论通过2种不同药理作用的联合---玻璃酸钠的黏弹性充填作用与乙哌立松的缓解疼痛及痉挛作用,可使对膝关节骨关节炎的临床疗效明显优于单药应用。
    Abstract: Objective To compared the efficacy of hyaluronan combined with eperisone hy-drochloride or simple application of hyaluronan or eperisone hydrochloride in the treatment of pa-tients with knee osteoarthritis (OA).Methods 99 patients with knee OA were randomly divided into hyaluronan group,eperisone hydrochloride group and combined group (hyaluronan combined with eperisone hydrochloride),33 cases in each group.Efficacy was compared among 3 groups. Rsults 5 weeks after treatment,WOMAC score of combined group was significantly higher than hyaluronan group and eperisone hydrochloride group.The CTX-Ⅱ content of urine in combined group was significantly lower than the other two groups (P <0.05).Conclusion Combination of hyaluronan and eperisone hydrochloride can significantly improve the clinical symptoms of patients with knee OA,and its efficacy is obviously better than simple application of hyaluronan or eperisone hydrochloride.
  • 期刊类型引用(2)

    1. 李玲玲,匡歆,王贵平,于风格. LAMP-CRISPR/Cas12a技术在重症肺炎病原体检测中的应用. 检验医学与临床. 2025(03): 415-419+423 . 百度学术
    2. 郭建懿,王晓林,郝晓飞,杜娟,武星光. 肺炎支原体肺炎患儿血清总IgE、CCSP、TIM-3与病情严重程度和预后的关系研究. 现代生物医学进展. 2024(17): 3279-3283 . 百度学术

    其他类型引用(1)

计量
  • 文章访问数: 
  • HTML全文浏览量: 
  • PDF下载量:  0
  • 被引次数: 3
出版历程
  • 发布日期:  2014-07-14

目录

    /

    返回文章
    返回
    x 关闭 永久关闭

    根据国家关于期刊质量管理的相关要求,为加强学术诚信体系建设,防范学术不端风险,《实用临床医药杂志》要求文章重复率不超过20%。即日起,请作者在向《实用临床医药杂志》投稿前先通过维普、万方等权威数据库进行论文查重检测。作者通过投审稿系统投稿时,需要提交稿件及本文重复率不超过20%的查重检测报告。

    鉴于作者在外部渠道查重易造成论文与成果泄漏,《实用临床医药杂志》官网联系了维普论文检测系统(链接地址:https://vpcs.fanyu.com/personal/jcmp)、万方检测系统(链接地址:http://jcmp.wfcheck.cn/),便于作者进行预查重检测。维普论文检测系统、万方检测系统为第三方检测,具体事宜请作者与检测方接洽(维普联系电话:400-607-5550;万方联系QQ:800856851;电话:18677087062)。

    同时,《实用临床医药杂志》编辑部提醒广大作者尽早关注“实用临床医药杂志”官方微信公众号,并登陆官方网站及投审稿系统进行投稿。

     


    《实用临床医药杂志》官方微信二维码

     

     

    《实用临床医药杂志》官方网站三维码